Recent Analysts’ Ratings Changes for Bed Bath & Beyond (BBBY)

Bed Bath & Beyond (NASDAQ: BBBY) has recently received a number of price target changes and ratings updates:

  • 7/6/2017 – Bed Bath & Beyond was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.
  • 7/4/2017 – Bed Bath & Beyond had its “sell” rating reaffirmed by analysts at Loop Capital. They now have a $35.00 price target on the stock.
  • 7/4/2017 – Bed Bath & Beyond had its “hold” rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
  • 7/4/2017 – Bed Bath & Beyond had its price target lowered by analysts at Telsey Advisory Group from $42.00 to $41.00. They now have a “market perform” rating on the stock.
  • 7/4/2017 – Bed Bath & Beyond had its price target lowered by analysts at Wedbush from $42.00 to $38.00. They now have a “neutral” rating on the stock.
  • 6/28/2017 – Bed Bath & Beyond had its “buy” rating reaffirmed by analysts at Argus. They now have a $40.00 price target on the stock, down previously from $48.00.
  • 6/26/2017 – Bed Bath & Beyond had its “neutral” rating reaffirmed by analysts at BTIG Research.
  • 6/26/2017 – Bed Bath & Beyond had its “neutral” rating reaffirmed by analysts at UBS AG. They now have a $33.00 price target on the stock, down previously from $37.00.
  • 6/25/2017 – Bed Bath & Beyond had its price target lowered by analysts at Wolfe Research from $31.00 to $29.00. They now have an “underperform” rating on the stock.
  • 6/25/2017 – Bed Bath & Beyond had its “hold” rating reaffirmed by analysts at Deutsche Bank AG. They now have a $31.00 price target on the stock, down previously from $36.00.
  • 6/24/2017 – Bed Bath & Beyond was given a new $30.00 price target on by analysts at Wedbush. They now have a “hold” rating on the stock.
  • 6/24/2017 – Bed Bath & Beyond was given a new $27.00 price target on by analysts at Bank of America Corporation. They now have a “sell” rating on the stock.
  • 6/24/2017 – Bed Bath & Beyond was given a new $30.00 price target on by analysts at Morgan Stanley. They now have a “sell” rating on the stock.
  • 6/24/2017 – Bed Bath & Beyond had its “hold” rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
  • 6/23/2017 – Bed Bath & Beyond had its price target lowered by analysts at Bank of America Corporation from $35.00 to $30.00. They now have an “underperform” rating on the stock.
  • 6/23/2017 – Bed Bath & Beyond had its “neutral” rating reaffirmed by analysts at Wedbush.
  • 6/23/2017 – Bed Bath & Beyond had its price target lowered by analysts at Barclays PLC from $45.00 to $40.00. They now have an “equal weight” rating on the stock.
  • 6/23/2017 – Bed Bath & Beyond had its price target lowered by analysts at KeyCorp from $35.00 to $27.00. They now have an “underweight” rating on the stock.
  • 6/23/2017 – Bed Bath & Beyond had its “neutral” rating reaffirmed by analysts at Guggenheim.
  • 6/23/2017 – Bed Bath & Beyond had its price target lowered by analysts at Jefferies Group LLC from $41.00 to $34.00. They now have a “hold” rating on the stock.
  • 6/23/2017 – Bed Bath & Beyond had its “market perform” rating reaffirmed by analysts at Raymond James Financial, Inc..
  • 6/21/2017 – Bed Bath & Beyond had its price target lowered by analysts at Morgan Stanley from $38.00 to $35.00. They now have an “underweight” rating on the stock.
  • 6/20/2017 – Bed Bath & Beyond had its price target lowered by analysts at Telsey Advisory Group from $41.00 to $39.00. They now have a “market perform” rating on the stock.
  • 6/19/2017 – Bed Bath & Beyond was downgraded by analysts at Wolfe Research from a “peer perform” rating to an “underperform” rating. They now have a $31.00 price target on the stock.
  • 6/19/2017 – Bed Bath & Beyond had its “sell” rating reaffirmed by analysts at Goldman Sachs Group, Inc. (The). They now have a $38.00 price target on the stock.
  • 6/19/2017 – Bed Bath & Beyond had its “neutral” rating reaffirmed by analysts at Robert W. Baird. They now have a $38.00 price target on the stock, down previously from $42.00.
  • 6/12/2017 – Bed Bath & Beyond was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Bed Bath & Beyond has underperformed the broader industry in the last one year. The company has been reeling under sluggish mall traffic, with increasing shift toward online shopping. Also, margins have been pressurized owing to increased costs. Expecting these factors to linger, the company provided a dismal earnings view for fiscal 2017. Apart from this, Bed Bath & Beyond's global presence keeps it exposed to the threat of adverse currency fluctuations. On the positive side, however, the company is focused on strategic initiatives like store expansion, eCommerce enhancement and improvement of customer services. Further, contributions from One King Lane should enable Bed Bath & Beyond to fight competition from e-commerce giants and boost results. Additionally, the company's recent dividend hike underscores its financial strength. Estimates have been stable of late, ahead of the company's first-quarter earnings.”
  • 6/2/2017 – Bed Bath & Beyond was downgraded by analysts at ValuEngine from a “buy” rating to a “hold” rating.

Shares of Bed Bath & Beyond Inc. (NASDAQ BBBY) opened at 29.21 on Tuesday. The stock’s 50 day moving average is $34.41 and its 200-day moving average is $38.81. The stock has a market capitalization of $4.11 billion, a P/E ratio of 6.72 and a beta of 1.13. Bed Bath & Beyond Inc. has a one year low of $28.33 and a one year high of $48.83.

Bed Bath & Beyond (NASDAQ:BBBY) last issued its earnings results on Thursday, June 22nd. The retailer reported $0.58 earnings per share for the quarter, missing analysts’ consensus estimates of $0.66 by $0.08. The business had revenue of $2.74 billion during the quarter, compared to analyst estimates of $2.79 billion. Bed Bath & Beyond had a net margin of 2.75% and a return on equity of 11.20%. Bed Bath & Beyond’s revenue for the quarter was up .1% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.80 EPS. On average, equities research analysts expect that Bed Bath & Beyond Inc. will post $4.04 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 17th. Stockholders of record on Friday, September 15th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.05%. Bed Bath & Beyond’s dividend payout ratio is 13.86%.

In other news, CEO Steven H. Temares sold 200,000 shares of the company’s stock in a transaction dated Friday, April 21st. The stock was sold at an average price of $39.83, for a total value of $7,966,000.00. Following the transaction, the chief executive officer now owns 603,515 shares in the company, valued at approximately $24,038,002.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Steven H. Temares sold 96,109 shares of the company’s stock in a transaction dated Tuesday, May 9th. The shares were sold at an average price of $37.37, for a total value of $3,591,593.33. Following the completion of the transaction, the chief executive officer now owns 629,415 shares in the company, valued at approximately $23,521,238.55. The disclosure for this sale can be found here. Insiders sold a total of 349,706 shares of company stock worth $13,679,409 in the last quarter. 5.00% of the stock is owned by corporate insiders.

Bed Bath & Beyond Inc is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! (collectively, CTS), Harmon or Harmon Face Values (collectively, Harmon), buybuy BABY (Baby) and World Market, Cost Plus World Market or Cost Plus (collectively, Cost Plus World Market).

What are top analysts saying about Bed Bath & Beyond Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Bed Bath & Beyond Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit